nufarm methomyl 225 insecticide
nufarm australia limited - methomyl; methanol - liquid concentrate - methomyl carbamate-methylcarbamate active 225.0 g/l; methanol solvent other 472.0 g/l - insecticide - adzuki bean | apple | barley | blueberry | broad bean | broccoli | brussels sprouts | cabbage | canola | capsicum or pepper | ca - apple dimpling bug - c. liebknechti | armyworm | bean fly | bean podborer | bean thrip | bronze orange bug | budworms | buffel grass seed caterpillar | cabbage center grub | cabbage moth | cabbage white butterfly | chrysomelid beetle | cluster caterpillar | codling moth | common armyworm - mythimna convecta | corn earworm | cotton budworm or bollworm | cutworm - agrotis spp. | false wireworm - celibe spp. | grasshopper | green peach aphid | green vegetable bug | helicoverpa larvae | helicoverpa spp. | large citrus butterfly | leafhopper | light brown apple moth | longtailed mealy bug | looper | looper - chrysodeixis spp. | looper caterpillar - c. subsidens | lucerne blue butterfly | monolepta beetle | native budworm or bollworm | pea thrip | piezodorus spp. | plague thrips | podsucking bug | potato looper | potato moth | psyllid or lerp insect | riptortus spp. | seed-harvesting ant | small citrus butterfly | sorghum midge | southern or barley armyworm | spined or larger horned citrus bug | stubby root nematod
buprenorphine tablet
remedyrepack inc. - buprenorphine hydrochloride (unii: 56w8mw3en1) (buprenorphine - unii:40d3scr4gz) - buprenorphine sublingual tablets are indicated for the treatment of opioid dependence and are preferred for induction. buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. buprenorphine sublingual tablets are contraindicated in patients with a history of hypersensitivity to buprenorphine, as serious adverse reactions, including anaphylactic shock, have been reported [see warnings and precautions (5.9)]. risk summary the data on use of buprenorphine, the active ingredient in buprenorphine sublingual tablets, in pregnancy, are limited; however, these data do not indicate an increased risk of major malformations specifically due to buprenorphine exposure. there are limited data from randomized clinical trials in women maintained on buprenorphine that were not designed appropriately to assess the risk of major malformations [see data] . observational st
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-rel
bryant ranch prepack - dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi), amphetamine aspartate monohydrate (unii: o1zpv620o4) (amphetamine - unii:ck833kgx7e), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi), amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e) - dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules are indicated for the treatment of attention deficit hyperactivity disorder (adhd). the efficacy of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules in the treatment of adhd was established on the basis of two controlled trials in children aged 6 to 12, one controlled trial in adolescents aged 13 to 17, and one controlled trial in adults who met dsm-iv® criteria for adhd [see clinical studies (14)]. a diagnosis of adhd (dsm-iv® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better a
transfer aid, person, <specify>
ausmedic australia pty ltd -
15693 - transfer aid, person,
endoscope lens cleaner, single-use
koala medical pty ltd - 61204 - endoscope lens cleaner, single-use - a sterile device intended to be used for the in situ removal of blood/debris from the lens of an endoscope (e.g., laparoscope), by directing gas and/or liquid to the edge of the lens. it is typically a multichannel sleeve with connection tubing. gases/fluids are intended to be directed from a source through the channels within the sleeve to the lens. this is a single-use device.
irrigation/aspiration unit, endoscopic
koala medical pty ltd - 36023 - irrigation/aspiration unit, endoscopic - a mains electricity (ac-powered) device intended to generate positive pressure, to irrigate and clean the distal tip of an endoscope with sterile fluid/gas (e.g., saline water/co2) typically to facilitate observation of a site with an endoscope (e.g., during laparoscopy).
vivacor 10mg tablets
lexon (uk) ltd - bisoprolol fumarate - oral tablet - 10mg
hydrocodone bitartrate and acetaminophen tablet
redpharm drug, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate and acetaminophen tablets, usp are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings], reserve hydrocodone bitartrate and acetaminophen tablets, usp for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia hydrocodone bitartrate and acetaminophen tablets are contraindicated in patients with: significant respiratory depression [see warnings] acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings] known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings] hypersensitivity to hydrocodo
hydrocodone bitartrate and acetaminophen tablet
redpharm drug, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7) - hydrocodone bitartrate and acetaminophen tablets, usp are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings], reserve hydrocodone bitartrate and acetaminophen tablets, usp for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia hydrocodone bitartrate and acetaminophen tablets are contraindicated in patients with: significant respiratory depression [see warnings] acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings] known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings] hypersensitivity to hydrocodo
hydrocodone bitartrate and acetaminophen tablet
redpharm drug, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7) - hydrocodone bitartrate and acetaminophen tablets, usp are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings], reserve hydrocodone bitartrate and acetaminophen tablets, usp for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia hydrocodone bitartrate and acetaminophen tablets are contraindicated in patients with: significant respiratory depression [see warnings] acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings] known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings] hypersensitivity to hydrocodo